Actuate Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.11

-0.13 (-10.16%)

As of Aug 15, 2:17 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 90%

Hold 1 10%

Sell 0 0%

Price Target

Analyst Price Target +1,947.1% upside

Low Target $15.82

Average Target $22.62

High Target $24.89

Current Price $1.11

Current
$1.11

Target
$22.62

$15.82 $22.62 avg $24.89

Scenario Analysis

Bear Case

$15.82

1,331.7%

Low target

Base Case

$22.62

+1,947.1%

Avg target

Bull Case

$24.89

+2,152.5%

High target

Risk/Reward

1.6x

Balanced

Price in Context

52-Week High

$9.22

-88.0% from high

52-Week Low

$0.91

+21.2% from low

Target vs 52W High

$22.62

+145.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%